Synthesis and Evaluation of Thiazolyl-1H-benzo[d]imidazole Inhibitors of Mycobacterium tuberculosis Inosine Monophosphate Dehydrogenase

AUTOR(ES)

Pissinate, Kenia, Rostirolla, Diana Carolina, Pinheiro, Laura Miranda, Suryadevara, Priyanka, Yogeeswari, Perumal, Sriram, Dharmarajan, Basso, Luiz Augusto, Machado, Pablo, Santos, Diógenes Santiago

FONTE

J. Braz. Chem. Soc.

DATA DE PUBLICAÇÃO

2015-07

RESUMO

Using an orthologue-based design approach, we synthesized and assayed a series of thiazolyl-1H-benzo[d]imidazole derivatives as inhibitors of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase (MtIMPDH). From these experiments, a benzo[d] imidazole compound was described to inhibit the enzyme in the low micromolar range (K_{i IMP} = 0.55 ± 0.02 µM), which places this compound among the most potent in vitro MtIMPDH inhibitors developed to date. In addition, steady-state kinetic measurements and docking simulations were employed to determine its inhibition and interaction modes. The results described herein may be useful for the design and development of novel alternative therapeutics for tuberculosis that target MtIMPDH, a predicted to be essential (for optimal in vitro bacillus growth), druggable and assayable molecular target.

Documentos Relacionados

• Dormancy models for Mycobacterium tuberculosis: A minireview
• A new synthesis of inosine from 5-amino-1-beta-D-ribofuranosyl-4-imidazole-carboxamide.
• Design, Synthesis and Antitubercular Activity of 2-(Benzylthio)-1H-benzo[d]imidazoles
• In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1
• Targeted Disruption of the Inosine 5′-Monophosphate Dehydrogenase Type I Gene in Mice